Avanza Fonder Ab Revolution Medicines, Inc. Transaction History
Avanza Fonder Ab
- $3.38 Trillion
- Q2 2025
A detailed history of Avanza Fonder Ab transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 3,688 shares of RVMD stock, worth $170,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,688
Previous 2,877
28.19%
Holding current value
$170,385
Previous $99.5 Million
36.3%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
331Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$728 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$662 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$619 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$489 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$474 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.05B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...